ACADIA Pharmaceuticals Inc (ACAD)

Add to Watchlists
Create an Alert
21.54 -0.23  -1.06% NASDAQ Jan 17, 16:11 Delayed 2m USD
View Full Chart
ACAD Price Chart
View All Key Stats

ACAD Key Stats

View All ACAD News

ACAD News

View All Events

ACAD Events

Date Type Description
02/27/2019 17:00 EST Misc ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
02/27/2019 Earnings ACADIA Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release
11/06/2018 17:00 EST Misc ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018
11/06/2018 Earnings ACADIA Pharmaceuticals Inc Third Quarter Earnings in 2018 Release
08/08/2018 17:00 EDT Misc ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018
08/08/2018 Earnings ACADIA Pharmaceuticals Inc Second Quarter Earnings Results in 2018
06/06/2018 Misc ACADIA Pharmaceuticals Inc Annual General Meeting in 2017
05/04/2018 08:30 EDT Misc ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018
05/04/2018 Earnings ACADIA Pharmaceuticals Inc First Quarter Earnings Results in 2018
02/27/2018 17:00 EST Misc ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017
View All Performance Charts

ACAD Total Returns Comparison

ACAD Fundamentals

Income Statement View Statement

Revenue (TTM) 207.80M
Total Expenses (TTM) 457.98M
Net Income (TTM) -248.57M

Balance Sheet View Statement

Total Assets (Quarterly) 266.46M
Total Liabilities (Quarterly) 43.02M
Shareholders Equity (Quarterly) 223.44M

Cash Flow Statement View Statement

Cash from Operations (TTM) -158.39M
Cash from Investing (TTM) 99.37M
Cash from Financing (TTM) 10.84M

ACAD Ratings

Advertisement

ACAD One Page Reports

ACAD Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 21.54
Price Target Upgrade
Price Target Upside (Daily) Upgrade
Edit

Profile

  • URL: http://www.acadia-pharm.com
  • Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 27, 2019
  • Last Earnings Release: Nov. 06, 2018
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: ACADIA Pharmaceuticals Inc is a biotechnology company which develops and commercializes biopharmaceutical products to address central nervous system disorders. It aims to discover small molecule drugs to address Parkinson’s, Alzheimer’s and schizophrenia.

ACAD Comparables

Edit
HALO Halozyme Therapeutics Inc
ALNY Alnylam Pharmaceuticals Inc
ARNA Arena Pharmaceuticals Inc
ARRY Array BioPharma Inc
NKTR Nektar Therapeutics Inc

ACAD Excel Add-In Codes

  • Name: =YCI("ACAD","name")
  • Description: =YCI("ACAD","description")
  • Sector: =YCI("ACAD","sector")
  • Industry: =YCI("ACAD","industry")
  • Est. Current Fiscal Year End: =YCI("ACAD","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Other ACAD Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.